Abducens palsy and Sjogren's syndrome induced by pegylated interferon therapy.
Oishi
Akio
A
Miyamoto
Kazuaki
K
Kashii
Satoshi
S
Yoshimura
Nagahisa
N
D020434:Abducens Nerve Diseases / Q000139:chemically induced*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D010243:Paralysis / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D012859:Sjogren's Syndrome / Q000139:chemically induced*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a